Biovilda M-500 is a combination tablet containing Vildagliptin (50 mg) and Metformin Hydrochloride (500 mg), used for the management of type 2 diabetes. Vildagliptin is a DPP-4 inhibitor that helps increase insulin release and decrease glucagon production, thus lowering blood sugar levels after meals. Metformin works by improving insulin sensitivity and reducing glucose production in the liver. Together, these medications effectively control blood sugar, improve glycemic control, and help manage type 2 diabetes, promoting overall metabolic health.
Reviews
There are no reviews yet.